Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daniele Veritti, Valentina Sarao, Valentina Soppelsa & Paolo Lanzetta. (2021) Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options. Clinical Ophthalmology 15, pages 375-385.
Read now
Read now
Articles from other publishers (4)
Shelby Sydnor, Swarnendu Chatterjee, Philip Cooney, Simarjeet Kaur, Tom Macmillan, Daisy Stewart, Isobel Munro, Cátia Bandeiras, Abby Paine & Federico Felizzi. (2023) Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis. Diabetes Therapy 14:7, pages 1193-1216.
Crossref
Crossref
Xiao Xie, Chao Lian, Zhiping Zhang, Meng Feng, Wenqi Wang, Xiaomeng Yuan, Yanmei Shi & Tingting Liu. (2023) Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis. Frontiers in Endocrinology 14.
Crossref
Crossref
Paula Montes Rodríguez, Javier Mateo Gabás, Olivia Esteban Floría, Ana Honrubia Grijalbo & Francisco J. Ascaso Puyuelo. (2022) Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema. Cost Effectiveness and Resource Allocation 20:1.
Crossref
Crossref
Sangeetha Santhakumaran, Ali Salimi, VanessaC Brunetti & John Galic. (2022) Efficacy and safety of aflibercept therapy for diabetic macular edema: A systematic review and meta-analysis. Journal of Current Ophthalmology 34:2, pages 133.
Crossref
Crossref